Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.022
Sell
RSI(14)
32.676
Neutral
STOCH(KDJ)(9,3,3)
20.459
Buy
ATR(14)
0.047
High Vlolatility
CCI(14)
-80.530
Neutral
Williams %R
82.170
Oversold
TRIX(12,20)
-1.294
Sell
StochRSI(14)
100.000
Buy
Search
cbdMD Inc
YCBDAdd to Watchlist
0.509USD
+0.038+8.05%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.12MMarket Cap
0.02P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+8.05%
5 Days
-5.41%
1 Month
-24.38%
6 Months
-51.07%
Year to Date
-62.30%
1 Year
-43.27%
Key Figures
0.490Open
0.534High
161.43KVolume
0.02P/E TTM
LossP/E Dynamic
--Dividend TTM
1.60%Turnover Ratio
0.471Prev. Close
0.480Low
60.64KTurnover
LossP/E Static
0.57P/B
0.00%Div Yield TTM
-22.91%ROA
2.56052wk High
0.72Volume Ratio
-7.70MNet Profit
10.07MShares
28.1293EPS TTM
2.15Beta
-62.55%ROE
0.47052wk Low
11.49%Amplitude
53.29%Gross Margin
5.12MMarket Cap
-3.53Reward/Risk
8.85%Risk Rate
TradingKey Stock Score of cbdMD Inc
Currency: USD Updated: 2026-07-31Key Insights
cbdMD Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 68 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.00.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
cbdMD Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
cbdMD Inc Highlights
StrengthsRisks
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Growing
The company is in a growing phase, with the latest annual income totaling USD 19.19M.
Overvalued
The company’s latest PE is 0.02, at a high 3-year percentile range.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
2.000
Target Price
+309.00%
Upside Space
cbdMD Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
1
analysts
Buy
Current Rating
2.000
Target Price
+309.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
cbdMD Inc
YCBD
1
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Indicators
Moving Average
Indicators
Value
Direction
MA5
0.497
Buy
MA10
0.532
Sell
MA20
0.614
Sell
MA50
0.677
Sell
MA100
0.731
Sell
MA200
0.832
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
cbdMD Inc Info
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Ticker SymbolYCBD
CompanycbdMD Inc
CEOKennedy (T. Ronan)
Websitehttps://www.cbdmd.com/
Shareholders
Related Instruments
-0.53%
+0.23%
-1.00%
-2.54%
+0.33%
-1.44%
-0.61%
-0.79%
-8.78%
+0.48%
+0.70%
-1.00%
-0.69%
+0.49%
-1.08%
+3.32%
0.00%
+1.34%
-0.87%
-2.17%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of cbdMD Inc (YCBD)?
The current price of cbdMD Inc (YCBD) is 0.51.
What is the symbol of cbdMD Inc?
The ticker symbol of cbdMD Inc is YCBD.
What is the 52-week high of cbdMD Inc?
The 52-week high of cbdMD Inc is 2.56.
What is the 52-week low of cbdMD Inc?
The 52-week low of cbdMD Inc is 0.47.
What is the market capitalization of cbdMD Inc?
The market capitalization of cbdMD Inc is 5.12M.
Is cbdMD Inc (YCBD) currently rated as Buy, Hold, or Sell?
According to analysts, cbdMD Inc (YCBD) has an overall rating of Buy, with a price target of 2.00.
What is the Earnings Per Share (EPS TTM) of cbdMD Inc (YCBD)?
The Earnings Per Share (EPS TTM) of cbdMD Inc (YCBD) is -1.09.